| GOLDMAN SACHS EMERGING MARKETS EQUITY PORTFOLIO BASE USD DIS | RVI EMERGENTES | 53,28% | 74,95% | 24,87% | 137,45% |
| AMUNDI MSCI JAPAN ESG BROAD TRANSITION INDEX RE CAP | RVI JAPÓN | 35,57% | 56,27% | 57,40% | 137,42% |
| BGF EURO-MARKETS A2 EUR | RV EURO | 17,64% | 45,93% | 47,80% | 137,40% |
| JANUS HENDERSON FUND PAN EUROPEAN SMALL AND MID-CAP A2 EUR | RVI EUROPA SMALL/MID CAP | 14,23% | 33,52% | 20,07% | 137,40% |
| J O HAMBRO CAPITAL MANAGEMENT GLOBAL SELECT FUND A EUR | RVI GLOBAL | 20,67% | 44,44% | 20,24% | 137,38% |
| BGF EUROPEAN VALUE A2 USD | RVI EUROPA VALOR | 23,81% | 58,52% | 77,75% | 137,37% |
| VONTOBEL FUND-US EQUITY C USD CAP | RVI USA CRECIMIENTO | -5,49% | 12,22% | 21,02% | 137,32% |
| BRANDES GLOBAL VALUE FUND I1 GBP DIS | RVI GLOBAL VALOR | 18,17% | 52,53% | 69,02% | 137,31% |
| SCHRODER ISF JAPANESE OPPORTUNITIES A ACC USD | RVI JAPÓN VALOR | 41,65% | 63,24% | 69,33% | 137,31% |
| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) CHF-H1 | RVI BIOTECNOLOGÍA | 81,95% | 100,76% | 59,34% | 137,28% |
